Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
Go back to Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 444.93 -0.11 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $445.04 | 52 Week High | $134.71 | |||
| Open | $440.02 | 52 Week Low | $73.31 | |||
| Day High | $447.70 | P/E | N/A | |||
| Day Low | $440.02 | EPS | $-1.98 | |||
| Volume | 924,190 | |||||
